Oxford Cancer Analytics (OXcan)
Oxford Cancer Analytics (OXcan) develops blood tests for early cancer detection using advanced proteomics and AI. Their protein-based blood test identifies molecular signatures for high-risk lung cancer patients, offering a minimally invasive and accurate method for early detection. OXcan leverages a diverse global biobank to ensure worldwide scalability of its technology.
Buy Funded Startups lists
Funding Round: Series A
Funding Amount: $11M
Date: 09-Jan-2025
Investors: We Venture Capital, Cross-Border Impact Ventures, Eka Ventures, Civilization Ventures, DigitalDx Ventures, Macmillan Cancer Support (Innovation Impact Investment Portfolio), Aurelium Ventures, OKG Capital, prominent angel investors
Markets: Medtech, Diagnostics, AI, Proteomics, Biotechnology, Health Care, Health Diagnostics
HQ: Oxford, England, United Kingdom
Founded: 2018
Website: https://www.oxcan.org/
LinkedIn: https://uk.linkedin.com/company/oxford-cancer-analytics
Crunchbase: https://www.crunchbase.com/organization/oxcan
Leave a Comment
Comments
No comments yet.